The significance of surgery for bulky N2 small-cell lung cancer: A clinical and in vitro analysis of long-term survivors

Surgery Today

Volumn 30, Issue 11, 2000, Pages 978-986

  Kobayashi, Shunsuke ^a   Okada, Shinichiro ^a   Hasumi, Toru ^a   Sato, Nobuyuki ^a   Fujimura, Shigefumi ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

Bulky N2; Combined modality therapy; Long term survival; Small cell lung cancer; Tissue culture

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; NIMUSTINE; VINCRISTINE; VINDESINE;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; DRUG SENSITIVITY; HUMAN; HUMAN CELL; LUNG CANCER; LUNG SMALL CELL CANCER; MALE; POSTOPERATIVE CARE; TISSUE CULTURE;

EID: 0033636891     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005950070017     Document Type: Article

References (24)

1. A randomized clinical trial in bronchogenic small-cell carcinoma evaluating alternating maintenance therapy of vincristine, adriamycin, procarbazine, and etoposide (VAPE) with cyclophosphamide, CCNU, and methotrexate (CCM) versus CCM maintenance alone in complete responders following VAPE induction and late intensification
2. Dose intensity of the CAVE regimen in small cell lung cancer correlates to response rate
3. Chemotherapy with vincristine/ifosfamide/carboplatin/etoposide in small cell lung cancer
4. Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma
5. Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: A randomized study
6. Intensive chemotherapy with autologous bone marrow transplantation for small cell lung carcer
7. Treatment-related deaths in small cell lung cancer trials: Can patients at risk be identified?
8. Risk of recurrence and/or second lung cancer after treatment of patients with small cell lung cancer (SCLC)
9. Effects of therapy on the morphology and behavior of small cell carcinoma of the lung - A clinico-pathologic study
10. Morphologic changes following therapy
11. The importance of surgery as the first step in multimodality treatment of small cell bronchial carcinoma
12. Adjuvant chemotherapy following surgical resection for small cell carcinoma of the lung
13. Multimodality therapy for small cell carcinoma of the lung - The role of surgical treatment
14. Surgical treatment of small cell lung cancer
15. Culture and changes in dynamics of proliferation of pulmonary small cell carcinoma cells
16. Combined modality therapy including surgery for Stage III small cell lung cancer on the basis of the sensitivity assay in vitro
17. A convenient and inexpensive chemoradiosensitivity assay for lung cancer cells using Terasaki's microplate
18. Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing
19. Long-term survival five years or more after combination chemotherapy and radiotherapy for small cell lung cancer
20. Small cell carcinoma of the lung, a progress report of 15 years experience
21. Longevity in small cell lung cancer. A report to the lung cancer subcommittee of the United Kingdom Coordinating Committee for Cancer Research
22. In vitro radiation sensitivity of established cell lines of human small cell lung cancer and its large cell morphologic variants
23. Resectability of small-cell lung cancer following induction chemotherapy in patients with limited disease (stage II-IIIb)
24. Influence of surgical resection before and after chemotherapy on survival in small cell lung cancer